| Event chart MODERNA, INC. |
|
|
|
| Upcoming events on MODERNA, INC. |
|
| 08/10/22 | | Interim 2022 Earnings Release (Projected) |
| 11/03/22 | | Q3 2022 Earnings Release (Projected) |
| 02/23/23 | | FY 2022 Earnings Release (Projected) |
| 05/11/23 | | Q1 2023 Earnings Release (Projected) |
|
| Past events on MODERNA, INC. |
|
| 05/24/22 | 09:15am | | UBS Global Healthcare Conference |
| 05/17/22 | 09:00am | | Investor Day - Science and Technology Day |
| 05/04/22 | 08:00am | | Q1 2022 Earnings Call |
| 05/04/22 | 06:52am | | Q1 2022 Earnings Release |
| 04/28/22 | 08:00am | | Annual General Meeting |
| 03/24/22 | 07:00am | | Investor Day - Vaccines |
| 03/17/22 | 09:00am | | Oppenheimer Healthcare Conference |
| 03/15/22 | 12:30pm | | Barclays Global Healthcare Conference |
| 03/09/22 | 09:10am | | Cowen & Co. Health Care Conference |
| 02/24/22 | 08:00am | | FY 2021 Earnings Call |
|
| Past dividends on MODERNA, INC. |
|
- No events available -
|
|
|
| Fiscal Period : December | 2018 | 2019 | 2020 | 2021 | 2022 |
Sales
M $ |
Released
Forecast
Spread | 135
124
8,8% | 60,2
63,6
-5,3% | 803
502
60% | 18 471
17 940
3,0% |
22 069
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | -388
-340
-14% | -515
-536
4,0% | -732
-507
-44% | 13 528
12 626
7,1% |
13 713
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | -413
-378
-9,3% | -546
-537
-1,6% | -763
-582
-31% | 13 296
12 562
5,8% |
13 688
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | -384
-380
-1,1% | -515
-533
3,4% | -745
-575
-29% | 13 285
12 585
5,6% |
13 673
|
Net income
M $ |
Released
Forecast
Spread | -402
-370
-8,6% | -514
-517
0,63% | -747
-582
-28% | 12 202
11 445
6,6% |
11 501
|
EPS
$ |
Released
Forecast
Spread | -1,22
-1,27
3,7% | -1,55
-1,56
0,79% | -1,96
-1,25
-57% | 28,3
26,9
5,2% |
27,2
| | Announcement Date | 03/06/2019 | 02/26/2020 | 02/25/2021 | 02/24/2022 | - |
|
|
|
| Fiscal Period : December | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 |
Sales
M $ |
Released
Forecast
Spread | 8,39
17,6
-52% | 66,4
24,2
174% | 158
82,5
91% | 571
279
104% | 1 937
2 061
-6,0% | 4 354
4 233
2,8% | 4 969
6 285
-21% | 7 211
6 735
7,1% | 6 066
4 426
37% |
4 105
|
5 932
|
6 128
|
3 205
|
2 430
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread |
|
|
|
|
|
|
| 5 488
4 948
11% |
|
|
|
|
|
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | -131
-134
2,0% | -122
-128
4,3% | -235
-153
-54% | -275
-132
-108% | 1 266
947
34% | 3 062
2 858
7,1% | 3 558
4 467
-20% | 5 410
4 727
14% | 4 227
2 790
51% |
2 226
|
3 590
|
3 616
|
1 405
|
735
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | -124
-127
2,5% | -117
-120
2,8% | -233
-146
-59% | -271
-124
-118% | 1 260
964
31% | 3 063
2 754
11% | 3 552
4 409
-19% | 5 410
4 629
17% | 4 229
2 829
49% |
2 150
|
3 729
|
3 680
|
1 413
|
743
|
Net income
M $ |
Released
Forecast
Spread | -124
-127
2,5% | -117
-120
2,9% | -234
-145
-61% | -272
-128
-112% | 1 221
832
47% | 2 780
2 467
13% | 3 333
3 946
-16% | 4 868
4 145
17% | 3 657
2 419
51% |
1 914
|
2 998
|
2 865
|
1 139
|
595
|
EPS
$ |
Released
Forecast
Spread | -0,35
-0,37
4,3% | -0,31
-0,34
8,8% | -0,59
-0,38
-57% | -0,69
-0,41
-67% | 2,84
2,10
35% | 6,46
5,59
16% | 7,70
9,11
-15% | 11,3
9,61
18% | 8,58
5,63
52% |
4,76
|
7,13
|
6,67
|
2,69
|
1,40
| | Announcement Date | 05/07/2020 | 08/05/2020 | 10/29/2020 | 02/25/2021 | 05/06/2021 | 08/05/2021 | 11/04/2021 | 02/24/2022 | 05/04/2022 | - | - | - | - | - | |
|
|
| Upcoming sector events for MODERNA, INC. |
|
| |
|
| Past sector events for MODERNA, INC. |
|
| |
|
|
|
|
Pfizer's $11.6 billion Biohaven buy could spark more biotech deals |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
Previous year
